AKBA — Akebia Therapeutics Share News
0.000.00%
Last trade - 00:00- $305.81m
- $337.17m
- $236.20m
Brief: Akebia Therapeutics Completed Type A Meeting With The FDA
Brief: Akebia Therapeutics Announces Positive Top-Line Results Of Phase 4 Impact Study Of Auryxia® (Ferric Citrate) For In-Center And Home Dialysis Patients
Brief: Akebia Announces Swissmedic Approval Of Vafseo
U.S. STOCKS ON THE MOVE-Home Depot, Netflix, Bunge
U.S. STOCKS ON THE MOVE-Manchester United, China ADRs, Adobe
Akebia Therapeutics appoints new CFO, shares rises
Brief: Akebia Therapeutics Announces New Chief Financial Officer
U.S. STOCKS ON THE MOVE-Ford Motor, Theratechnologies, 3D Systems
Brief: Akebia Therapeutics Says, On May 30, Unit And Panion & BF Biotech Entered A Settlement And License Agreement - Filing
Akebia Therapeutics rises on patent conflict settlement with Zydus
Brief: Akebia Therapeutics Inc - On May 26, Entered Into Assignment & Assumption Of Lease With Lg Chem Life Sciences Innovation Center, Inc
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
U.S. STOCKS ON THE MOVE-Arlington Asset Investment, Redwoods, GreenLight Biosciences
Akebia Therapeutics up after FDA outlines plan to resubmit NDA for anemia treatment
Brief: FDA Provides Akebia Therapeutics a Path Forward For Vadadustat
Brief: Akebia Therapeutics Enters Into License Agreement With Medice Arzneimittel Pütter GmbH&Co.KG For The Commercialization Of Vafseo For The Treatment Of Anemia Associated With CKD In Europe And Australia
Brief: Akebia Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines